Alpha Teknova (TKNO) Non Operating Income (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Non Operating Income of -$210000.0 for Q1 2026, down 161.58% year-over-year from $341000.0 in Q1 2025, and little changed quarter-over-quarter from -$211000.0 in Q4 2025.
Alpha Teknova (TKNO) Non Operating Income (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Non Operating Income for 7 consecutive years, with -$210000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income fell 161.58% year-over-year to -$210000.0; the TTM figure through Mar 2026 stood at -$776000.0 (down 286.07% YoY), while the FY2025 annual figure was -$225000.0, up 67.25% from the prior year.
- Non Operating Income steadied at -$210000.0 in Q1 2026 per TKNO's latest filing, from -$211000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $341000.0 in Q1 2025 and bottomed at -$1.4 million in Q3 2023.
- Historically, Non Operating Income has averaged -$139352.9 across 5 years, with a median of -$141000.0 in 2024.
- On a YoY basis, Non Operating Income climbed as much as 953.85% in 2023 and fell as far as 1403.77% in 2023.
- Alpha Teknova's Non Operating Income stood at $147000.0 in 2022, then plunged by 169.39% to -$102000.0 in 2023, then decreased by 26.47% to -$129000.0 in 2024, then slumped by 63.57% to -$211000.0 in 2025, then rose by 0.47% to -$210000.0 in 2026.
- Business Quant data shows TKNO's Non Operating Income at -$210000.0 in Q1 2026, -$211000.0 in Q4 2025, and -$190000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alpha Teknova | 396.90 Mn | 379.46 Mn | 4.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -210,000.00 |
| Dec 31, 2025 | -211,000.00 |
| Sep 30, 2025 | -190,000.00 |
| Jun 30, 2025 | -165,000.00 |
| Mar 31, 2025 | 341,000.00 |
| Dec 31, 2024 | -129,000.00 |
| Sep 30, 2024 | -141,000.00 |
| Jun 30, 2024 | -272,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | -102,000.00 |
| Sep 30, 2023 | -1.38 Mn |
| Jun 30, 2023 | -142,000.00 |
| Mar 31, 2023 | 111,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | 106,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | -74,000.00 |
| Sep 30, 2021 | -255,000.00 |
| Jun 30, 2021 | -307,000.00 |